Brian Wanamaker is a criminal defense attorney with Ritchie, Dillard, Davies & Johnson. This column is provided through the Knoxville Bar Association.
Most companies expect the occasional civil judgment or fine; they rarely expect to plead guilty to a criminal offense. Global health care company Abbott Laboratories Inc. recently agreed to do just that to resolve civil and criminal liability issues related to off-label marketing of its anti-seizure medication Depakote. Abbott agreed to plead guilty to one misdemeanor and pay about $1.6 billion. That is one hefty misdemeanor.
Read the full story at: